2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edemaeye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorderRecruitingPhase 22026-09-09NCT06825702
Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trialdiabetic macular edemaActive, not recruitingPhase 42026-04-17NCT05610319